Background Fibroblast growth factor 23 (FGF23) levels increase as kidney function
decreases and are associated with increased mortality in patients with chronic kidney …

Background Secondary hyperparathyroidism, a condition of excess parathyroid hormone
(PTH, Pth) production, is often seen in chronic kidney disease (CKD) patients with elevated …

Plasma adrenomedullin concentrations are reportedly elevated in patients with renal failure;
however, the underlying mechanism is unclear. In this study, we investigated the plasma …

Purpose Although fibroblast growth factor-23 (FGF23) is involved in the development of
metabolic diseases, its association with metabolic-associated fatty liver disease (MAFLD) …

Background: People with HIV and hepatitis C virus (HCV) coinfection experience excess
mortality because of multiple causes. Identification of biomarkers associated with mortality …

ABSTRACT Fibroblast growth factor 23 (FGF23) is an endocrine hormone that stimulates
renal phosphate excretion and suppresses circulating concentrations of 1, 25 …

Phosphate (Pi)-containing food additives are used in several forms. Polyphosphate (PPi)
salt has more harmful effects than monophosphate (MPi) salt on bone physiology and renal …

Background: Cardiovascular events are the main cause of death in patients with chronic
kidney disease. We hypothesize that the protective effects of renal cholesterol and vitamin …

Introduction: QTc interval prolongation is increasingly frequent as chronic kidney disease
(CKD) advances and predicts death in dialysis. However, predictors and mortality risk in …

Цель исследования. Установить зависимость между концентрацией фактора роста
фибробластов-23 (FGF-23, пмоль/л) и показателями центральной гемодинамики у …